top of page

Equity Considerations in Injury Compensation

I had the great opportunity today to address the National Academies of Science, Engineering, and Medicine’s committee on Equity Considerations in Injury Compensation. I discussed my more than 20 years experience in the National Vaccine Injury Compensation Program, how the NVICP evolved and how Congress’ failure to modernize the Program is causing crushing delays.


0 views0 comments

Recent Posts

See All

Unfortunately, they're exactly what we expected. There was one payout for anaphylaxis ($2,019.55), and two myocarditis ($1,582.65 and $1,032.69). You can track the awards here. The CICP is not a reaso

As March winds down and the days grow warmer and longer, perhaps like me, your thoughts turn to spring cleaning. That time of year where you clean out the nooks and crannies and corners of your home t

bottom of page